Objectives: To assess the frequency and diversity of extended spectrum b-lactamases (ESBLs) in the Champagne-Ardenne region France, and to identify genetic elements associated with the bla CTX-M genes.
Introduction
Since the 1980s extended-spectrum b-lactamases (ESBLs) related to TEM-and SHV-type enzymes have been widely observed, mostly in Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae and more rarely in Escherichia coli.
1,2
The numerous amino acid substitutions that occurred led to a great diversity of TEM-type (more than 150) and SHV-type (more than 85) enzymes. In the early 2000s, new non-TEM non-SHV ESBLs (CTX-M, PER-1 and VEB-1) were reported in epidemic clones of Enterobacteriaceae involved in hospitalacquired outbreaks in South America, Asia and particularly in Turkey and Eastern Europe. 3 -10 Before 2000, these new types had rarely been identified in France. 7, 11 Thereafter, whereas most of the TEM-or SHV-type-producing strains were hospital-acquired, the CTX-M types were chiefly community-acquired, 12 thus making the spread of these ESBLs more difficult to control. The reservoir of most bla CTX-M was identified as Kluyvera spp. 13 An ISEcp1-like insertion sequence was identified upstream of the bla CTX-M genes, associated with four out of the five bla CTX-M clusters (CTX-M-1, M-2, M-9 and M-25) with variations in the intergenic sequences upstream and downstream of the bla CTX-M genes. 14, 15 Among these genes, bla CTX-M-2 , bla CTX-M-9 and bla CTX-M-20 were sometimes linked to ISCR1, a sequence-type termed 'common region' (CR) that is often found beyond but close to the 3 0 conserved sequences of class 1 integrons. 16 These CRs resemble an atypical class of insertion sequences designated IS91-like. 17 ISCR1 accommodates a transposase gene, Orf513. The aim of this study was to assess the frequency and diversity of ESBLs produced by strains of Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii in the ChampagneArdenne region in eastern France, to detect epidemic clonal strains and to explore the insertion sequences associated with bla CTX-M .
Materials and methods

Selection of clinical isolates
The Champagne-Ardenne region has a population of 1.34 million. The survey was conducted in the University hospital, the nine largest non-teaching public hospitals in the region and three private clinics from 1 January to 31 December 2004. All the non-duplicate isolates of P. aeruginosa and A. baumannii resistant to ceftazidime (MIC .32 mg/L) and of Enterobacteriaceae intermediate or resistant to ceftazidime and/or cefotaxime (MICs .4 mg/L) and/or aminoglycosides with an AAC(6 0 ) I phenotype intermediate or resistant to amikacin (MIC .8 mg/L), kanamycin (MIC .8 mg/L) and tobramycin (MIC .4 mg/L) were collected and sent every 3 months to the Reims hospital laboratory. All isolates from inpatients and outpatients were included, irrespective of where they were sampled or of their implication in infection. Screening samples, such as anal swabs, were excluded. For infections to be defined as hospital-acquired, they had to occur at least 48 h after admission during a stay within the survey period. Every 4 months, two strains, some of them producing an ESBL, were sent to each laboratory as quality controls.
Identification, susceptibility testing and confirmation of ESBL detection
Identification of the strains was verified by Rapid ID 32 E for Enterobacteriaceae and ID 32 GN for P. aeruginosa and A. baumannii (bioMérieux, Marcy l 0 É toile, France) and antibiotic susceptibilities were determined by the disc diffusion method according to the recommendations of the Antibiogram Committee of the French Society for Microbiology (http://www.sfm.asso.fr/). Strains were screened for ESBL by the double-disc synergy test 18 and with discs containing 30 mg of cefotaxime or ceftazidime alone and in combination with 10 mg of clavulanate (CDO2 and CDO3, Oxoid SA 69571 Dardilly France) onto Mueller-Hinton agar with and without 200 mg/L cloxacillin. Isoelectric focusing (IEF) was carried out for all the isolates ESBL-positive with these tests.
IEF assay and ESBL identification
b-Lactamases were prepared by sonication from culture in Trypticase soy broth using a Vibra cell 72412 (Fisher Bioblock Scientific, BP 50111, 67403 Illkirch cedex, France). Analytical IEF was performed in 6% polyacrylamide gels containing ampholines with a pH range of 3.5-10. Proteins were focused at a constant temperature (68C) for 1. Genes bla TEM , bla SHV , bla CTX-M and bla OXA were detected by PCR using specific primers as previously described for all the ESBL-producing strains (Table 1) . 3,4,6,10,19 -22 The sequences were determined by direct sequencing of PCR products, performed by the dideoxy chain termination procedure of Sanger et al. 23 on an Applied Biosystems 3730 XL DNA analyser using the BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, USA). PCR and sequencing were performed for all ESBL-producing strains, but for Enterobacter aerogenes isolates producing an ESBL of pI 6.5 they were performed for one strain of each antibiotic-associated resistance phenotype. When sequencing was not performed enzymes were designated TEM-24-like.
RAPD typing
The isolates were genotyped by RAPD to study their clonal diversity using RAPD analysis primer 2 [ 
Genetic environment of bla CTX-M genes
To investigate the genetic structures at the origin of bla CTX-M gene acquisition, the genetic environment of bla CTX-M was characterized by PCR with the primers listed in Table 1 . Whole-cell DNA of isolates was extracted as described previously. 24 As bla CTX-M genes have often been reported in class 1 integrons downstream of a common region ISCR1 associated with Orf513 or downstream of an insertion sequence ISEcp1, the regions upstream of bla CTX-M genes were amplified with forward primers hybridizing to the insertion sequences ISEcp1, to the region Orf513 and the bla CTX-M reverse primer (CTX-MA2). 13 The genetic sequences located downstream of different bla CTX-M genes were studied by PCR experiments with Extended-spectrum b-lactamase regional incidence in France the forward primer CTX-MA1 and the reverse primer CTX-M-preB or IS903Bint (Table 1) . When Orf513 was found upstream of bla CTX-M , a PCR experiment was performed with primer CTX-MA1 and reverse primer qacED1B to search for a sul1-type integron structure as previously described. 13, 25 The prevalence of ESBLs was calculated using the number of non-duplicate isolates in each species and each centre. The x 2 test was used to compare distributions with previous reports.
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Results
Selection of clinical isolates
A total of 21 861 isolates of Enterobacteriaceae, 2345 P. aeruginosa and 186 A. baumannii were identified. Of the 504 resistant isolates included in the study, 138 Enterobacteriaceae (0.6% of the 21 861), 5 A. baumannii (2.7% of the 186) and 2 P. aeruginosa (0.08% of the 2345 isolates) produced an ESBL. They were isolated from urine (n ¼ 115), respiratory tract samples (n ¼ 13), blood cultures (n ¼ 8), wounds (n ¼ 7) and catheters (n ¼ 2). Among Enterobacteriaceae, the most frequent species were E. coli (n ¼ 69) and E. aerogenes (n ¼ 50). The prevalence of ESBL production in each Enterobacteriaceae species taken separately was 14.7% for E. aerogenes, 1.0% for E. cloacae, 0.6% for K. pneumoniae, 0.5% for E. coli, 0.3% for Citrobacter koseri and 0.1% for Proteus mirabilis.
ESBL production and antimicrobial susceptibilities of the ESBL-producing strains
The ESBLs produced were TEM-type (n ¼ 64), CTX-M-type (n ¼ 62), SHV-type (n ¼ 13) and VEB-1 (n ¼ 6). The rates of ESBL-producing bacteria and enzyme-type distribution varied according to centres, mainly because of A. baumannii VEB-1, E. aerogenes TEM-24 and E. coli CTX-M-15 outbreaks (Table 2) . Most ESBLs were CTX-M-type (16/23, 69.6%) in centre C and TEM-type (29/37, 78.4%) in centre B. Isolates acquired during a hospital stay (n ¼ 72: 49.7%) were more often observed among TEM-(n ¼ 44: 68.6%) and VEB-type (n ¼ 5: 83.3%) than among CTX-M-(n ¼ 19: 30.6%) and SHV-type (n ¼ 4: 30.8%). In Enterobacteriaceae, they were more often resistant to ciprofloxacin (57/66, 86.4% versus 51/72, 70.8%; P ¼ 0.02) and to amikacin (42/66, 63.6% versus 31/72, 43.1%; P ¼ 0.02) than isolates present at admission or in outpatients. This was not the case for gentamicin (16/ 
ESBL identification
Of the TEM-type ESBLs (n ¼ 64), 52 were TEM-24-like enzymes, mostly from E. aerogenes (n ¼ 50, 96.1%) and also from E. cloacae (n ¼ Table 2) . Three of them were isolated in several centres; V in centres A, C, E and H, III in centres A and J of the same city and IV in centres A and D. In centre C, it was related to the admission of patients from the same long-stay care unit.
SHV-type enzymes (n ¼ 13) were SHV-12 from E. cloacae (n ¼ 4), E. coli (n ¼ 2), K. pneumoniae (n ¼ 1) and C. freundii (n ¼ 1); SHV-2 (n ¼ 1), SHV-5 (n ¼ 1) and new SHV from K. pneumoniae (n ¼ 1); and SHV2a from P. aeruginosa (n ¼ 2). The new SHV differed from SHV-1 by a D214G substitution. One non-TEM-, non-SHV-type enzyme, VEB-1 (n ¼ 6) was produced by A. baumannii (n ¼ 5) and Enterobacter sakazakii (n ¼ 1). VEB-1-producing A. baumannii isolates had the same genotype and were responsible for an outbreak in three hospitals. 27 
Genetic environment of bla CTX-M genes
The genetic environment of the bla CTX-M gene was studied for 27 strains producing CTX-M-1 (n ¼ 7), CTX-M-2 (n ¼ 4), CTX-M-9 (n ¼ 1), CTX-M-14 (n ¼ 3), CTX-M-15 (n ¼ 11) and CTX-M-16 (n ¼ 1) with different resistance phenotypes, and/or RAPD patterns. Insertion sequence ISEcp1 was identified upstream of bla CTX-M genes in 22 strains (Figure 1 ). In four strains (GI4014, EY4012, SD4014 and TR4095), PCR amplification was obtained with ISEcp1 promþ primer but not with ISEcp1A primer, suggesting the presence of the disrupted IS element. These DNA sequences contained a putative promoter region probably involved in the transcription of downstreamlocated bla CTX-M genes. 14 The right boundary of ISEcp1 was located between 43 and 80 bp upstream of the start codon of bla CTX-M genes. ISEcp1 was identified at 80 bp upstream Table 2 . (12) 14 (11) 23 (16) 23 (11) 8 (4) 4 2 (2) 6 (2) 2 (1) 13 (10) E. cloacae (11) 30 (22) 6 (5) 10 (6) 1 (1) 0 2 (1) Extended-spectrum b-lactamase regional incidence in France 
Continued of bla CTX-M-1 genes and at 48 bp (W sequence) upstream of bla CTX-M-15 genes (Figure 1 ). The 48 bp shared 100% nucleotide identity with the 48 bp upstream of bla CTX-M-1 genes. The distance between ISEcp1 and the start codon of bla CTX-M-9 -like (bla CTX-M-14 and bla CTX-M-16 ) genes was identical at 43 bp ( Figure 1) . Downstream of bla CTX-M-9 -like genes, an IS903-like element was found. ISEcp1 was not identified upstream of bla CTX-M-2 and bla CTX-M-9 genes. Consequently, the ISCR1 was sought and found in all the strains harbouring those genes. However, the collinearity between ISCR1 and bla CTX-M-2 was found only in one strain, RS4076. This bla CTX-M-2 gene was located in a sul1-type class 1 integron.
Discussion
Before 2004, a progressive increase in the prevalence of CTX-M-type enzymes was observed in different areas in France, 11, 28, 29 but in our region no information was available. To compare data between different surveys, the MIC and specimen criteria for isolate inclusion were the same as previously reported.
7,11 Some ESBL-producing isolates with both cefotaxime and ceftazidime MICs 4 mg/L may have been missed. This has been reported for some TEM-or SHV-type-producing P. mirabilis and K. pneumoniae but not for CTX-M-typeproducing strains. 30, 31 To avoid misdetection of ESBL masked by Ambler class C cephalosporinase, synergy tests were repeated on Mueller-Hinton agar containing 200 mg/L cloxacillin.
The prevalence of ESBL production in Enterobacteriaceae isolated during our survey (0.6%) was lower than in the French data obtained in 1998 (3.2%; P , 10 27 ) but similar to those obtained in 2001 -02 (0.8%). 7, 11, 28 In comparison with the Auvergne 2001 -02 and Nîmes distribution of the ESBLs among Enterobacteriaceae, 11, 29 our survey underlines the increase in CTX-M-type (44.9% versus 3.7% and 10.0%; P , 10 27 ), linked to E. coli expansion, as reported around the world. 4, 8, 12, 21, 24, 32, 33 In this species, CTX-M types (82.8% ESBL), more frequent than in previous studies, 29, 32 were mainly CTX-M-15 (52.2% ESBL and 63% CTX-M-type) probably due to a plasmid and a clonal E. coli dissemination. 33 A decrease in TEM-type (46.4% versus 95.0% and 90.0% in Auvergne and Nîmes; P , 10 27 ), with the disappearance of most TEM-3 (0.9% versus 51.2% and 42.5%) and an increase in SHV (8.0% versus 1.3% and 0.0%; P ¼ 0.001) were observed (Table 4) as reported in Paris hospitals in 2002, earlier than in other French areas.
11,28,29 SHV-type enzymes have rarely been reported in P. aeruginosa, but SHV-2a has been observed in France. 34 Inter-hospital transmission of isolates has been previously reported for E. aerogenes TEM-24 and A. baumannii VEB-1. In our survey, these strains had the same genotype pattern as the clonal strains previously reported mainly in northern France in 2003 -04. 7, 12, 27 The index case of A. baumannii VEB-1 in centre A was one patient transferred from centre B in 2003. In our region, the epidemic was efficiently controlled by hygiene measures and no case was identified after 2004.
Repeated admission of patients from geriatric centres, such as 15 isolates of E. coli CTX-M-15 in centre C, can be a source of nosocomial CTX-M-type E. coli. 35 The presence of three epidemic genotypes (III, IV and V) in centre A can be explained by its role as a tertiary hospital admitting patients from the other centres.
In early reports, ESBLs were very often associated with aminoglycoside and quinolone resistances. 2 Associated resistances have been less frequently reported among patients in the community, 12 as observed in our study on ciprofloxacin and amikacin resistance. The high frequency of the combination of ciprofloxacin resistance 32 with CTX-M-15 enzyme that was more frequent in nosocomial isolates, and conversely the high frequency of co-trimoxazole resistance in other CTX-M-type enzymes isolates from the community showed that associated resistance in ESBL producers may depend on the antibiotics used, respectively, in hospitals and in the community.
bla CTX-M genes have often been reported downstream of an insertion sequence ISEcp1 or in complex class 1 integrons downstream of a common region ISCR1 and associated with Orf513. ISCR1 is mainly associated with bla CTX-M-2 , bla CTX-M-9 and bla CTX-M-20 genes. 16, 17 In three CTX-M-2 isolates and one CTX-M-9 isolate in our study, the association was suggested by PCR results, but collinearity was not found. This suggests that either ISCR1 was not linked to bla CTX-M or that the bla CTX-M gene was not in a class 1 integron. Several bla CTX-M have been reported, bracketed by an ISEcp1-like element upstream and an IS903-like element downstream such as bla CTX-M-14 . 25 The role of the IS903-like element is not fully understood. 15 The present report is the first to identify the genetic environment of the bla CTX-M-16 gene, which combines a disrupted ISEcp1 upstream, as in some CTX-M-1-and CTX-M-15-producing strains, a Y sequence between ISEcp1 and bla CTX-M and IS903 downstream of bla CTX-M as bla CTX-M-14 . These two enzymes belong to the same bla CTX-M-9 group, and our results are consistent with the hypothesis of the same progenitor. 3, 21 The variability in ISEcp1 size for the same CTX-M enzyme gene illustrates the circulation of sporadic strains among clonal strains. Taken together these results provide strong evidence that ISEcp1 plays a major role in the spread and expression of bla CTX-M genes in Enterobacteriaceae.
Previously ESBL-producing strains were mainly nosocomial. 2, 7, 11 The emergence of ESBL isolates in the community, Extended-spectrum b-lactamase regional incidence in France mainly due to CTX-M other than CTX-M-15, is an additional problem for the control of nosocomial ESBL-producing strains. Extended-spectrum b-lactamase regional incidence in France
